Table 8 Comparing the rate of HBV-DNA turning negative between observation and control groups n (n %).

From: Evaluation of the efficacy of Biejia decoction pill combined with entecavir in the treatment of hepatitis B liver fibrosis/cirrhosis by VCTE

Course (months)

3

6

9

12

Observation group (119)

50 (42.02%)

81 (68. 07%)

104 (87.39%)

113 (94.96%)

Control group (120)

45 (37.50%)

69 (57.50%)

85 (70.83%)

92 (76.67%)

χ2

0.509

2.855

9.906

16.383

P

0.476

0.091

0.002

 < 0.001

Back to article page